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Abstract 
Background and Aims: Patients with alcohol-related cirrhosis (ALD) are prone to infection. 
Circulating neutrophils in ALD are dysfunctional and predict development of sepsis, organ 
dysfunction and survival. Neutrophil granules are important effector organelles containing a 
toxic array of microbicidal proteins, whose controlled release is required to kill micro-
organisms whilst minimising inflammation and damage to host tissue. We investigated the 
role of these granular responses in contributing to immune disarray in ALD.  
Methods: Neutrophil granular content and mobilisation was measured by flow cytometric 
quantitation of cell-surface/intracellular markers, [secretory vesicles (CD11b), secondary 
granules (CD66b) and primary granules (CD63; myeloperoxidase)] before and after bacterial 
stimulation in 29 patients with ALD cirrhosis (15 abstinent; 14 actively drinking) compared to 
healthy controls (HC). ImageStream Flow Cytometry characterised localisation of granule 
subsets within the intracellular and cell-surface compartments.  The plasma cytokine 
environment was analysed using ELISA/Cytokine Bead Array.    
Results: Circulating neutrophils were primed in the resting state with upregulated surface 
expression of CD11b (p=0.0001) in a cytokine milieu rich in IL-8 (p<0.001) and lactoferrin 
(p=0.035). Neutrophils showed exaggerated mobilisation to the cell surface of primary 
granules at baseline (p=0.001) and in response to fMLP (p=0.009) and E. coli (p=0.0003). 
There was no deficit in granule content or mobilisation to the cell membrane in any granule 
subset observed. Paradoxically, active alcohol consumption abrogated the hyper-responsive 
neutrophil granular responses compared to their abstinent counterparts. 
Conclusions: Neutrophils are pre-primed at baseline with augmented effector organelle 
mobilisation in response to bacterial stimulation; neutrophil degranulation is not a 
mechanism leading to innate immunoparesis in ALD.  
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New and Noteworthy: 
• Neutrophil granules are upregulated in alcohol-related cirrhosis (ALD) at baseline 
and demonstrate augmented responses to bacterial challenge. 
• The granular responses in ALD did not contribute to the observed functional deficit 
in innate immunity, but rather, were dysregulated and hyper-responsive which may 
induce bystander damage to host tissue. 
• Paradoxically, active alcohol consumption abrogated the excessive neutrophil 
granular responses to bacterial stimulus compared to their abstinent counterparts.  
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Background 
The incidence and prevalence of cirrhosis is fast increasing and it is now the fifth most 
common cause of death in the United Kingdom with mortality rates predicted to double 
within 20 years (10). Susceptibility to infection remains one of the main concerns in patients 
with cirrhosis with a variety of components of the innate immune system reported to be 
dysfunctional. Bacterial infection is demonstrable in 34-44% of patients admitted to hospital 
(8, 18) and the risk of infection correlates with the severity of cirrhosis (11). Infections 
frequently precipitate decompensation and multiple organ failure (MOF) and are associated 
with a high mortality rate; infections increase mortality more than three-fold in cirrhosis and 
confer a damning prognosis, with 30% of patients dying in the first month after infection 
and 60% after 1 year (5, 17).  
Neutrophils are key players in the innate immune system providing the first line of defence 
against bacterial infection and constitute 40-60% of the white blood cell population. 
Neutrophils travel in a resting state in the healthy adult circulation with their microbicidal 
proteins stored intracellularly in granules and with low levels of reactive oxygen species 
(ROS) generated in the resting state (7). A number of abnormalities in neutrophil physiology 
have been reported in the context of cirrhosis; neutrophils have been shown to have 
impaired chemotaxis (12, 15, 20), opsonisation (26, 35), phagocytosis (19, 30) and elevated 
spontaneous ROS production (27). Furthermore, the degree of neutrophil dysfunction 
observed in patients with cirrhosis has been shown to be predictive of the risk of infection, 
organ failure and mortality (34). Neutrophil dysfunction in cirrhosis has been shown to be 
reversible with ex-vivo removal of endotoxin from patient plasma reducing oxidative burst 
and increasing phagocytic function (25) and normalisation of neutrophil cytokine profiles in 
alcoholic hepatitis after steroid administration (33).   
Neutrophil granules are a diverse population of intracellular organelles that develop at 
sequential stages of myeloid differentiation and contain a specific milieu of proteins 
(representative of the evolving cellular transcriptome) with targeted functions. Neutrophil 
granules are mobilised and released at the cell surface and in the endo-phagosome in 
ordered sequence throughout neutrophil activation (6). Granule release is necessary for 
adhesion, diapedesis, chemotaxis and the eventual release of potent microbicidal peptides 
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at sites of inflammation and infection. This ordered and controlled sequence serves to 
minimise bystander damage to host tissue in healthy states (31) [Figure 1].   
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Figure 1 
 
Figure 1: Graphic representation of neutrophil function, demonstrating conversion from a 
circulating inactive immune cell to targeted degranulation and phagocytosis at sites of 
inflammation (modified from Borregaard et. al (7)). The process occurs via sequential control 
of neutrophil granules which contain specific arrays of proteins which serve specific and 
timely functions relating to neutrophil activation.  
Initial interaction occurs with the vascular endothelium via selectins and cell adhesion 
molecules which facilitate rolling, adhesion and subsequently diapedesis across the 
endothelial membrane into the interstitial space. This in turn allows hierarchical activation of 
the neutrophil with mobilisation of granules to the cell surface and release of chemokines, 
cytokines and microbicidal proteins in a time ordered sequence, allowing the neutrophil to 
migrate to areas of inflammation and release microbicidal proteins and reactive oxygen 
species at targeted areas.  
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Secretory vesicles are formed late in neutrophil maturation via endocytosis and contain 
membrane-bound molecules including CD11b (32) that aid in neutrophil adhesion and 
migration; these organelles are the easiest granule sub-type to mobilise to the cell 
membrane. Tertiary (gelatinase) granules contain an array of metalloproteinases which are 
felt to aid neutrophil migration within the interstitial tissue but are not interrogated in this 
study. Secondary (specific) granules are characterised by the presence of lactoferrin (14) 
and other antimicrobial proteins and have CD66b as a granule-marker (16). Secondary 
granules are released at sites of infection alongside primary granules. CD63 is a lysosomal 
membrane protein located on neutrophil primary (azurophil) granules (13) and mobilises to 
the cell membrane on stimulation where primary granules release their microbicidal 
contents which include myeloperoxidase (MPO) (28).   
Data so far on the role of neutrophil granules in innate immune function in the context of 
cirrhosis is sparse and contradictory with studies demonstrating both normal degranulation 
patterns and impaired granule release upon response to bacterial stimulation (22, 30). 
Neutrophils have been shown to have reduced MPO release in response to bacterial peptide 
stimulation in the context of ALD in addition to reduced cell surface CD11b expression (9, 
24). Further characterisation of this immunological deficit, crucial to innate immune system 
function, will enhance understanding of one of the major causes of morbidity and mortality 
in liver disease and potentially elucidate therapeutic targets. 
We hypothesised that either a quantitative deficit in neutrophil granular content exists, or 
that there is an impairment of response to bacterial stimulation in terms of mobilisation of 
granule content and extracellular release; these contributing to the observed increased risk 
of bacterial infection in cirrhosis. The aim of this study was to characterise neutrophil 
granule mobilisation and release in patients with alcohol-related cirrhosis (ALD cirrhosis) 
compared to healthy controls (HC) in order to further delineate mechanisms of innate 
immune system compromise in ALD patients and identify potential therapeutic targets for 
intervention.  
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Materials and Methods 
Study Design 
Twenty nine patients with ALD cirrhosis were recruited including 15 actively drinking and 14 
abstinent and compared to HC (n=12). The patients with ALD cirrhosis were recruited from 
both outpatient clinics and inpatient wards. A history of excess alcohol intake was defined 
from thorough clinical history as >80 g/day for men and >60 g/day for women. Abstinence 
was defined as >6 months without alcohol consumption.  ALD cirrhosis was defined on the 
presence of either histological criteria, characteristic radiological findings or typical clinical 
presentation encompassing the presence of ascites, varices or encephalopathy. Alcoholic 
hepatitis was defined clinically with a typical history of excess alcohol intake, biochemical 
parameters meeting a minimum modified Maddrey’s discriminant function of ≥32 (23) and 
the absence of other causes of liver disease. Patients were followed longitudinally for 1 year 
and data on subsequent development of sepsis, death or liver transplantation were 
recorded.   
Inclusion Criteria 
Patients with ALD were included if they were >18 and <75 years and had provided consent 
for study inclusion. Healthy age- and sex-matched, non-smoking volunteers with no history 
of liver disease were used as HC. The HC alcohol intake was <20g/day and volunteers had 
not drunk alcohol or exercised excessively in the 72 hours prior to blood being drawn.  
Exclusion Criteria 
Patients were excluded from the study if, on presentation, they had evidence of bacterial, 
viral or fungal infection on the basis of clinical examination, laboratory and radiological 
investigation, malignancy, and any coexisting history of immunodeficiency, HIV infection or 
glycogen storage disease. Patients were also excluded if they were taking any concurrent 
immunosuppressive medications.  
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Consent and Data Collection 
The study was performed in accordance with the Declaration of Helsinki and ethical 
permission was granted from the North East London Research Committee (Ref. No. 
08/H0702/52). Following obtaining fully informed consent, clinical, biochemical, and 
physiological data were collected. Data included tobacco and alcohol use, electrolytes and 
renal function, liver function tests, differential leukocyte counts and clotting parameters. 
Child-Pugh (CP) (29) and model for end-stage liver disease (MELD) (21) organ severity scores 
were calculated.     
Sample Collection 
Venous blood was collected from patients/volunteers into heparinised pyrogen-free tubes 
and was immediately pre-cooled to 4oC until experimental use. Neutrophil granular 
phenotype and functional tests were performed within 1 hour of blood being drawn. Plasma 
was obtained by centrifuging whole blood at 4,500 rpm for 10 minutes at 4oC and stored at -
80oC for subsequent cytokine determination by enzyme-linked immunosorbent assay 
(ELISA) and cytometric bead array (CBA). 
Characterisation of neutrophil extracellular granular phenotype at baseline, and after 
stimulation with bacterial peptides 
One hundred microlitre aliquots of heparinised blood were placed into pyrogen-free tubes 
containing 380 µL of Rosenwall Park Memorial Institute (RPMI)-1640 media (Sigma-Aldrich, 
U.K.). Samples were stimulated with either 20 µL of opsonised E. coli (1.5 x 109 cells/ml) or 
20 µL fMLP (N-formyl-L-methionyl-L-leucyl-L-phenylalanine) 0.2µM (Becton-Dickenson [BD} 
U.K.) along with control (phosphate-buffered saline [PBS]). Samples were incubated at 37oC 
for 20 minutes and the reaction was stopped by adding 3 ml of PBS.  
The incubated whole-blood cell pellet was then stained with fluorochrome-conjugated 
monoclonal antibodies [(anti-human CD66b IgM κ, anti-human CD63 IgG1 κ, anti-human 
CD11b IgG1 κ, anti-human myeloperoxidase (MPO) IgG1 κ, anti-human CD16 IgG1 κ) BD, UK] 
at room temperature in darkness for 30 minutes. After washing and centrifugation, red 
blood cells were lysed and re-suspended in 300 mL PBS and analysis using a FACS Canto II 
analyser and FACS Diva 6.1.2 software (BD, San Jose, CA). Granulocytes were gated from the 
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cell suspension based on forward and side scatter characteristics and the mean fluorescence 
intensity (MFI) of CD16 was measured. The CD16 positive granulocytes were gated as 
neutrophils and the MFI of CD11b, CD66b, CD63 and MPO was measured from this cell 
population.  
Characterisation of neutrophil intracellular granular phenotype at baseline, and after 
stimulation with bacterial peptides 
Samples were treated as previously described in the incubation and extracellular protocol, 
however for the intracellular staining, whole blood was first incubated with anti-CD16 
antibody before lysis and fixation and then permeabilisation using a cytofix/cytoperm 
solution (BD, UK). Permeabilised cells were then labelled with fluorochrome-conjugated 
monoclonal antibodies (anti-human CD66b IgM κ, anti-human CD63 IgG1 κ, anti-human 
CD11b IgG1 κ, anti-human myeloperoxidase (MPO) IgG1 κ) before washing, re-suspension 
and FACS analysis.  
Cytokine estimation 
Plasma levels of the pro- and anti-inflammatory cytokines (IFN-γ, IL-10, IL-2, IL-6, IL-8 and 
TNF-α) were determined from plasma and supernatant samples previously stored at -80oC 
using CBA (BD, UK) and results (pg/mL) were correlated with neutrophil granular phenotype, 
physiological and biological parameters.  
Lactoferrin quantification 
Baseline values of lactoferrin, representative of neutrophil secondary granular content were 
measured from patient plasma and incubation medium supernatants obtained by 
centrifugation at 4500rpm for 10 minutes at 4oC and stored at -80oC. Sandwich ELISA was 
performed using a Lactoferrin ELISA kit (Merck Millipore, Germany).  
Image Stream Analysis 
Data on the subcellular localisation of neutrophil granules was sought by using a similar 
incubation and fluorochrome-staining protocol for neutrophils from HC and ALD patients 
utilising an Image Streamx Mark II Analyser (Amnis, Seattle, USA) which combines the 
phenotyping capability of flow cytometry with the detailed imagery and functional insights 
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of microscopy. Comparisons of MFI when gating at the intracellular and cell-surface 
compartments were made.  
Statistical Analysis 
Where appropriate, values are expressed as mean, median and inter-quartile range. A 
paired t-test was used for comparisons pre- and post-stimulation and Mann-Whitney U test 
was used for comparison between 2 groups. When comparing 3 or more groups 
simultaneously, the Kruskal-Wallis was utilised with Dunn’s multiple comparison test. 
Pearson and Spearman correlations were used for parametric and nonparametric data, 
respectively. All statistical analyses were performed using GraphPad Prism 6.0 for Windows 
(GraphPad Software, Inc., San Diego, CA); p<0.05 was considered as statistically significant.  
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Results 
 
Patient demographics and clinical parameters  
The baseline demographics, biochemical parameters and disease severity scores of the 
patients studied are detailed in Table 1. There were trends towards slight increases in 
markers of liver disease severity and systemic inflammation seen in the actively drinking 
subset of ALD cirrhosis. In all patients there was no suspicion of active infection based upon 
clinical evaluation, biochemical and radiological findings. 
In those with ALD cirrhosis, 4 (14%) patients developed bacterial infections over the course 
of 1 year of follow up with infections equally distributed across abstinent and actively 
drinking arms. One year mortality was measured at 14%, with 2 patients dying from 
complications of severe sepsis and MOF, 1 from severe hepatic decompensation and 
hepatorenal syndrome and 1 from unrelated causes. Three abstinent ALD cirrhotic patients 
were transplanted within 12 months of enrolment into this study.   
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Table 1 
Study Group Data Healthy 
Controls 
Abstinent  Actively drinking Total 
Patient Study 
Group 
Number 12 15 14 29 
Age 34 (31-54) 54 (45-59) 53 (47-59) 54 (47-59) 
Sex        Male             6 8 11 19 
             Female 6 7 3 10 
Bilirubin (µmol/L) - 40 (30-57) 123 (56-316)* 52 (32-141) 
AST (iu/L) - 35 (28-58) 93 (80-138)* 70 (39-94) 
ALP (iu/L) - 123 (93-178) 153 (133-258) 140 (106-192) 
GGT (iu/L) - 65 (37-109) 251 (111-503)* 109 (58-337) 
Creatinine (µmol/L)  - 88 (62-103) 58 (43-90) 68 (52-99) 
INR - 1.53 (1.15-1.91) 1.56 (1.34-1.81) 1.53 (1.25-1.83) 
Albumin (g/L) - 32 (28-36) 27 (25-30)* 29 (26-35) 
WCC (x109/L) - 4.0 (3.4-5.6) 7.1 (5.7-10.6)* 5.64 (3.9-7.7) 
Platelets (x109/L) - 110 (67-129) 130 (110-181) 123 (92-148) 
CRP (mg/L) - 8.7 (5.3-17.7) 20.2 (11.0-42.1)* 12.1 (7.3-28.7) 
Child Pugh Score - 10 (7-11) 10 (9-12) 10 (8-11) 
MELD Score - 16 (10-21) 20 (16-25)* 18 (13-22) 
UKELD Score - 53 (52-58) 59 (55-62)* 56 (53-61) 
Average Alcohol 
Intake (g/day) 
- 0 143 (120-255) - 
 
Table 1: Study patient enrolment characteristics, describing age and sex distributions in 
addition to biochemical and organ severity scores between groups (expressed as median and 
inter-quartile range). MELD: model for end stage liver disease, UKELD: united kingdom 
model for end stage liver disease. Patients who were actively drinking had trends towards 
higher markers of liver disease and systemic inflammation (* p<0.05). 
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Neutrophil granular responses in healthy controls 
Similar responses to stimulation in healthy controls were seen in both secretory vesicle and 
secondary granule mobilisation to the cell membrane when comparing stimulation with 
both fMLP and opsonised E. Coli [Figure 2 a + b, c + d]; however, primary granule responses 
were significantly elevated after stimulation with E. Coli (p=0.0023) compared to fMLP 
stimulation [Figure 2 e + f]. A proof of principle Image Stream Flow cytometry plot of 
healthy control neutrophil phenotype demonstrated significant upregulation of CD11b, 
CD66b and CD63 at the cell surface in response to stimulation with both fMLP and E. Coli in 
keeping with our FACS Canto flow cytometric data; this was not powered to detect 
differences between HC and ALD cirrhosis patients [Figure 3]. This is in keeping our 
understanding of granule physiology with respect to the different levels of calcium-
dependant signalling required to mobilise specific granule subsets to the cell membrane 
[Figure 1] (3, 7).  
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Figure 2  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Extracellular staining in healthy volunteers of fluorochrome-labelled neutrophil 
granule markers for secretory vesicles (CD11b) (a + b), secondary granules (CD66b) (c + d) 
and primary granules (CD63) (e + f) pre- and post-stimulation with fMLP and opsonised E. 
coli. Secretory vesicles and secondary granules were similarly significantly upregulated upon 
stimulation with fMLP, a potent neutrophil chemotaxin, or opsonised E. Coli, however 
primary granules showed a significantly increased response to bacterial stimulation over 
fMLP (p=0.002).  
 
 
 
a) 
c) 
e) 
b) 
d) 
f) 
** ** 
 *  * 
 * 
* 
** 
p < 0.05 
p < 0.005 
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Figure 3  
 
Figure 3: Image Stream Flow Cytometry plots of a healthy volunteer demonstrating 
fluorochrome-labelled staining patterns at the cell surface (a - c) and intracellularly (d - f), at 
baseline (a + d), after stimulation with the potent neutrophil chemotaxin fMLP (b + e), and 
after stimulation with opsonised E. Coli (c + f). Primary granules (column 1), secondary 
granules (column 5) and secretory vesicles (column 6) are all upregulated at the cell surface 
in response to fMLP and E. Coli stimulation with a more robust response observed to E.Coli. 
Plots from patients with ALD cirrhosis were indistinguishable and did not reveal impaired 
granule mobilisation or localisation. 
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Secretory Vesicles 
CD11b, which is expressed in neutrophil secretory vesicles and on the cell surface and binds 
intercellular adhesion molecule 1 (ICAM-1) on the activated vascular endothelium to 
mediate neutrophil binding and initiate the process of extravasation, was significantly 
elevated in unstimulated neutrophils isolated from ALD patients when measured 
extracellularly (p=0.0001) [Figure 4a] and showed a tendency towards upregulation 
intracellularly. Secretory vesicle mobilisation to the cell membrane in response to bacterial 
stimulation was similar in ALD compared to HC, with no demonstrable deficit in secretory 
vesicular upregulation at the cell surface in response to bacterial stimulation in ALD 
cirrhosis.  
Neutrophils examined from patients with ALD cirrhosis were activated at baseline, pre-
primed to interact with and adhere to the vascular endothelium and had augmented 
responses to bacterial stimulation when compared to HC.   
Secondary Granules  
Secondary granule content and mobilisation, as measured by flow cytometric CD66b 
quantitation on extracellular staining, before and after bacterial stimulation, demonstrated 
no significant difference in the ALD cirrhosis cohort as compared against HC. Of note 
however, there was increased intracellular staining of secondary granules at baseline 
(p=0.025) with no impairment in extracellularisation of secondary granule content observed 
in the ALD cohort in keeping with a primed neutrophil phenotype. Baseline plasma levels of 
lactoferrin were significantly elevated [Figure 4b] in patients with ALD (p=0.035) compared 
to HC suggesting that neutrophils from patients with ALD cirrhosis display augmented 
secondary granule release in their circulating state.   
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Figure 4: Cell-surface expression of CD11b (a) comparing patients with ALD cirrhosis against 
HC at baseline, and following stimulation with the neutrophil chemotaxin fMLP and 
opsonised E. Coli. Neutrophils in patients with ALD cirrhosis showed increased expression of 
CD11b at the cell surface at baseline (p=0.001) and no impairment of granular mobilisation 
to the cell surface after stimulation with bacterial peptides. There was neither a quantitative 
secondary granular deficit, nor an impairment of granule mobilisation observed in patients 
with ALD cirrhosis and plasma levels of lactoferrin (b) were increased at baseline when 
compared to healthy volunteers (p=0.035), suggestive of increased resting secondary 
granule release.  
 
 
 
 
 
19 
 
Primary Granules  
CD63 expression was elevated when measured at the cell surface in patients with ALD 
cirrhosis both at baseline (p=0.0001) and after stimulation with fMLP (p=0.009) and E. Coli 
(p=0.0003) when compared against HC [Figure 5a]. This was matched by intracellular data 
which showed significant elevations in the intracellular concentrations of primary granules 
(p=0.0005) within the neutrophils of patients with ALD compared to HC [Figure 5b]. There 
was a tendency in ALD cirrhosis towards increased intracellular concentrations of MPO.  
Abstinence versus active-alcohol consumption in alcohol-related cirrhosis 
When compared to HC, ALD cirrhosis patients who were abstinent had significantly 
upregulated neutrophil granular function in comparison to HC (CD63 p<0.001, CD66b 
p<0.001); alcohol consumption appeared to abrogate the neutrophil pre-priming and 
exaggerated granular responses in ALD cirrhosis. Dampening of the exuberant neutrophil 
granular responses and apparent normalisation of their activated phenotype in active 
alcohol consumers were seen in all granule subsets examined [Figure 6] but were most 
significantly noted in the intracellular content of primary granules and secondary granules 
(p<0.0001).  
Neutrophil granular phenotype and severity of liver disease 
There was no observable difference in neutrophil granular phenotype categorised by MELD 
score; severity of liver disease did not appear to affect neutrophil granular function [Figure 
7].   
Plasma cytokine levels in alcohol-related cirrhosis 
Plasma from patients with ALD cirrhosis had significantly upregulated levels of IL-8 in 
comparison to HC (p<0.001). This is in keeping with the observations of pre-primed 
neutrophil phenotype in a pro-inflammatory cytokine milieu; there were no significant 
differences observed in measurements of IFN-γ, IL-10, IL-2, IL-6, IL-8, TNF-α; however trends 
towards pro-inflammatory cytokine profiles were seen in ALD [Figure 8].  
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Figure 5: Cell-surface (a) and intracellular (b) expression of CD63 comparing patients with 
ALD cirrhosis against healthy volunteers at baseline, and after stimulation with the 
neutrophil chemotaxin fMLP, and opsonised E. Coli. Neutrophils expressed significant 
upregulation at baseline in primary granule expression both intracellularly (p=0.0005: ***) 
and at the cell surface (p=0.001: **) in patients with ALD cirrhosis compared to healthy 
volunteers. Neutrophil primary granules were hyper-responsive with significant differences in 
mobilisation to the cell membrane after incubation with fMLP (p=0.009: **) and E. Coli 
(p=0.0003: ***).  
 
 
 
 
 
21 
 
 
Figure 6: Intracellular expression of primary [a (CD63)] and secondary [b (CD66b)] granule 
markers comparing actively drinking patients with ALD cirrhosis against those who had been 
abstinent for >6 months and healthy controls (Kruskal-Wallis with Dunn’s multiple 
comparison test analysis). Active alcohol consumption normalised the upregulated baseline 
granule expression and exaggerated response to bacterial stimulation that was seen across 
all granular subsets. The most significant impact was noted in intracellular staining of 
primary and secondary granules (p<0.001).  
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Figure 7: Correlation of extracellular (a, b, c) and intracellular (d, e, f) neutrophil granular 
marker expression at baseline in ALD cirrhosis when compared against MELD score. Severity 
of underlying liver disease did not correlate with changes in neutrophil granular expression 
at baseline or mobilisation in response to bacterial stimulus. Abstinent     , actively drinking                                                
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Figure 8: Supernatant cytokine measurements performed using cytokine bead array 
demonstrating non-significant trends towards upregulation of proinflammatory cytokines [a) 
IL-6, b) IL-8, d) INFγ and e) TNFα] in ALD cirrhosis. Conversely, anti-inflammatory cytokines 
[c) IL-10, f) IL-2] were downregulated in ALD cirrhosis.  
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Discussion 
We have demonstrated, contrary to our a priori hypothesis, that neutrophil granular 
physiology in ALD cirrhosis is neither quantitatively deficient nor is there any demonstrable 
impairment in granule mobilisation and release. Neutrophil granule hypo-responsiveness is 
therefore unlikely to be contributing to the innate immune paresis observed in ALD 
cirrhosis. This finding is contradictory to other data with respect to ALD cirrhosis (9, 24); 
however this is the first time that individual neutrophil granular subsets have been 
described in this context. Other studies have shown separate defects in neutrophil cellular 
processes that go some way towards explaining this functional deficit in response to 
bacterial challenge, with impaired chemotaxis (12, 15, 20), opsonisation (26, 35) and 
phagocytosis (19, 30) reported.  
Conversely, the pattern of neutrophil granule baseline expression confirms these 
neutrophils are activated in their circulating state in ALD cirrhosis. They have higher levels of 
CD11b both on their cell surface and intracellularly; by implication they are primed, more 
adhesive and liable to interact with the vascular endothelium. An elegant study published in 
1983 reporting increased neutrophil adherence to nylon fibre in vitro in the context of ALD 
cirrhosis corroborates this data (2).  
Furthermore, neutrophils from patients with ALD cirrhosis have increased staining of 
primary and secondary granules intracellularly at baseline and augmented granular release 
in response to chemotactic and bacterial stimuli when compared against HC. Neutrophils 
are therefore more likely to release their toxic granular contents in response to lower 
concentrations of bacterial stimulation and in higher levels than they are in healthy adults; 
this may lead to inappropriate and/or excessive granule release and tilt the spectrum of 
granule function towards creating an environment of oxidative stress and damage in host 
tissue. This paradigm of primed and inappropriately sensitised neutrophils gives weight to 
the suggestion that dysregulation of the innate immune system in ALD cirrhosis is a double-
edged sword, both contributing to the propensity to develop bacterial and fungal sepsis, 
and, in terms of granule hyper-responsiveness, the propensity to suffer the serious sequelae 
of sepsis.  
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When comparing neutrophil granular phenotype in ALD cirrhosis patients who are actively 
drinking alcohol against those who are abstinent, intracellular content of both primary and 
secondary granules was significantly elevated in the abstinent cohort but these changes 
were not seen in patients who were actively drinking. Neutrophil activation and the 
production of ROS have been shown to lead to hepatic injury in this context (4) and selective 
gut decontamination can prevent hepatic injury related to alcohol toxicity (1).  The effect of 
active alcohol consumption appears to dampen the neutrophil inflammatory responses 
across the board of neutrophil granular phenotype; this is in keeping with observations of 
the effects of alcohol on neutrophil ROS production (27, 34). Rebound hyper-responsiveness 
and increased neutrophil degranulation may cause bystander damage and worsen liver 
injury on cessation of alcohol consumption. This observation provides credence in the form 
of a proposed immunological mechanism for the frequently observed phenomenon of initial 
clinical deterioration on cessation of alcohol consumption however further mechanistic 
work is required here. We feel that the inclusion of actively drinking and abstinent ALD 
cirrhotic patients in our study is likely to explain the differences in observed granular 
phenotype described in recent papers from Markwick et. al and Boussif et. al (9, 24) whose 
patient cohorts were actively drinking patients with ALD cirrhosis and acute alcoholic 
hepatitis. Further studies are warranted to investigate the effects of active alcohol 
consumption upon neutrophil granule function, particularly interrogating whether this is a 
direct inhibitory effect on neutrophils or is related to a reduction in neutrophil priming via 
manipulation of the enteric microbiota and circulatory endotoxin burden.   
Infection and its propensity to evolve into severe sepsis and MOF in the context of cirrhosis 
remains a huge challenge facing patients and clinicians alike. In the face of a tide of rising 
liver disease it is crucial that we understand the immunological aberrancies underpinning 
this propensity toward the development of sepsis and poor patient performance in 
controlling and fighting infection. This will allow the selective targeting of innate 
immunological pathways.  
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Figures and Tables 
Table 1 
Study patient enrolment characteristics, describing age and sex distributions in addition to 
biochemical and organ severity scores between groups (expressed as median and inter-
quartile range). MELD: model for end stage liver disease, UKELD: united kingdom model for 
end stage liver disease. Patients who were actively drinking had trends towards higher 
markers of liver disease and systemic inflammation (* p<0.05). 
Figure 1 
Graphic representation of neutrophil function, demonstrating conversion from a circulating 
inactive immune cell to targeted degranulation and phagocytosis at sites of inflammation 
(modified from Borregaard et. al (7)). The process occurs via sequential control of neutrophil 
granules which contain specific arrays of proteins which serve specific and timely functions 
relating to neutrophil activation.  
Initial interaction occurs with the vascular endothelium via selectins and cell adhesion 
molecules which facilitate rolling, adhesion and subsequently diapedesis across the 
endothelial membrane into the interstitial space. This in turn allows hierarchical activation 
of the neutrophil with mobilisation of granules to the cell surface and release of 
chemokines, cytokines and microbicidal proteins in a time ordered sequence, allowing the 
neutrophil to migrate to areas of inflammation and release microbicidal proteins and 
reactive oxygen species at targeted areas.  
Figure 2  
Extracellular staining in healthy volunteers of fluorochrome-labelled neutrophil granule 
markers for secretory vesicles (CD11b) (a + b), secondary granules (CD66b) (c + d) and 
primary granules (CD63) (e + f) pre- and post-stimulation with fMLP and opsonised E. coli. 
Secretory vesicles and secondary granules were similarly significantly upregulated upon 
stimulation with fMLP, a potent neutrophil chemotaxin, or opsonised E. Coli, however 
primary granules showed a significantly increased response to bacterial stimulation over 
fMLP (p=0.002).  
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Figure 3  
Image Stream Flow Cytometry plots of a healthy volunteer demonstrating fluorochrome-
labelled staining patterns at the cell surface (a - c) and intracellularly (d - f), at baseline (a + 
d), after stimulation with the potent neutrophil chemotaxin fMLP (b + e), and after 
stimulation with opsonised E. Coli (c + f). Primary granules (column 1), secondary granules 
(column 5) and secretory vesicles (column 6) are all upregulated at the cell surface in 
response to fMLP and E. Coli stimulation with a more robust response observed to E.Coli. 
Plots from patients with ALD cirrhosis were indistinguishable and did not reveal impaired 
granule mobilisation or localisation. 
Figure 4  
Cell-surface expression of CD11b (a) comparing patients with ALD cirrhosis against HC at 
baseline, and following stimulation with the neutrophil chemotaxin fMLP and opsonised E. 
Coli. Neutrophils in patients with ALD cirrhosis showed increased expression of CD11b at the 
cell surface at baseline (p=0.001) and no impairment of granular mobilisation to the cell 
surface after stimulation with bacterial peptides. There was neither a quantitative 
secondary granular deficit, nor an impairment of granule mobilisation observed in patients 
with ALD cirrhosis and plasma levels of lactoferrin (b) were increased at baseline when 
compared to healthy volunteers (p=0.035), suggestive of increased resting secondary 
granule release.  
Figure 5 
Cell-surface (a) and intracellular (b) expression of CD63 comparing patients with ALD 
cirrhosis against healthy volunteers at baseline, and after stimulation with the neutrophil 
chemotaxin fMLP, and opsonised E. Coli. Neutrophils expressed significant upregulation at 
baseline in primary granule expression both intracellularly (p=0.0005: ***) and at the cell 
surface (p=0.001: **) in patients with ALD cirrhosis compared to healthy volunteers. 
Neutrophil primary granules were hyper-responsive with significant differences in 
mobilisation to the cell membrane after incubation with fMLP (p=0.009: **) and E. Coli 
(p=0.0003: ***).  
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Figure 6 
Intracellular expression of primary [a (CD63)] and secondary [b (CD66b)] granule markers 
comparing actively drinking patients with ALD cirrhosis against those who had been 
abstinent for >6 months and healthy controls (Kruskal-Wallis with Dunn’s multiple 
comparison test analysis). Active alcohol consumption normalised the upregulated baseline 
granule expression and exaggerated response to bacterial stimulation that was seen across 
all granular subsets. The most significant impact was noted in intracellular staining of 
primary and secondary granules (p<0.001).  
Figure 7:  
Correlation of extracellular (a, b, c) and intracellular (d, e, f) neutrophil granular marker 
expression at baseline in ALD cirrhosis when compared against MELD score. Severity of 
underlying liver disease did not correlate with changes in neutrophil granular expression at 
baseline or mobilisation in response to bacterial stimulus. Abstinent     , actively drinking      . 
Figure 8:  
Supernatant cytokine measurements performed using cytokine bead array demonstrating 
non-significant trends towards upregulation of proinflammatory cytokines [a) IL-6, b) IL-8, d) 
INFγ and e) TNFα] in ALD cirrhosis. Conversely, anti-inflammatory cytokines [c) IL-10, f) IL-2] 
were downregulated in ALD cirrhosis.  
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